2014 Conference

Download the Preliminary Program

Invited Speakers

Chaim Birnboim, MD
Founder & Chief Scientific Officer, DNA Genotek Inc.

Dr. Chaim Birnboim received his Medical Degree from the University of Manitoba and subsequently trained in Biochemistry and Molecular Biology at the University of Manitoba and the Albert Einstein College of Medicine in New York.   read more »  

Thomas L. Force, MD
Professor of Medicine & Associate Director, Center for Translational Medicine, Temple University School of Medicine

Dr. Thomas Force is Professor of Medicine and Associate Director of the Center for Translational Medicine at Temple University School of Medicine. He received his A.B. from Harvard College, and his MD from Harvard Medical School. read more »

Paul Lem, MD
Chief Executive Officer, Spartan Bioscience

Dr. Paul Lem is the CEO of Spartan Bioscience—the leader in on-demand DNA testing. Prior to Spartan, Paul served as VP, Product Management at DNA Genotek. He was also founder and CEO of Plexagen. Paul holds a medical degree from the University of Ottawa, and graduated from the inaugural class of Singularity University.

Philip Marsden, MD, FRCPC
Professor of Medicine
Keenan Chair in Medical Research, St Michael’s Hospital
Oreopoulos-Baxter Division Director of Nephrology
Department of Medicine, University of Toronto

Dr. Philip Marsden is a clinician scientist trained at the Brigham and Women’s Hospital in Boston. He established an independent laboratory in 1991 at the University of Toronto and St. Michael’s Hospital, where he is presently Professor of Medicine, the Keenan Chair in Medical Research and the University of Toronto Division Director of Nephrology. read more »

Brian O’Rourke, B.Sc
President & Chief Executive Officer, Canadian Agency for Drugs and Technologies in Health

Dr. Brian O’Rourke is the President and Chief Executive Officer of the Canadian Agency for Drugs and Technologies in Health (CADTH). He joined CADTH in January of 2009 as the Vice-President of the Common Drug Review (CDR) following a distinguished career as a Pharmacist and Health Services Operations Officer with the Canadian Forces. read more »

Naveen L. Pereira, MD
Consultant, Division of Cardiovascular Diseases
Assistant Professor of Medicine, Mayo Clinic College of Medicine

Naveen L. Pereira, M.D., is a Consultant for the Division of Cardiovascular Diseases and Assistant Professor of Medicine, Mayo Clinic College of Medicine. He is board certified in internal medicine and cardiovascular diseases.  read more »

Pei Pei Ping, PhD, FAHA
Professor of Medicine & Physiology
Cardiovascular Research Laboratory, UCLA

Dr. Pei Pei Ping is internationally recognized for her expertise and achievements in cardiac organellar biology, functional ‘omics, and data science. The Ping laboratory has extensively characterized many proteomic alterations underlying cardiac organellar function and disease phenotypes (Drews et al. Circ Res, 2010; Lau, Wang et al. Circ Res, 2012; Wang, Fang, Zong et al. MCP, 2013).  read more »

William Stanford, MD
Senior Scientist, Sprott Centre for Stem Cell Research, The Ottawa Hospital Research Institute

Dr. William (Bill) L. Stanford, PhD, is a Senior Scientist at the Sprott Centre for Stem Cell Research at the Ottawa Hospital Research Institute (OHRI), a Full Professor in the Department of Cellular and Molecular Medicine at the University of Ottawa and holder of a Tier 1 Canada Research Chair in Integrative Stem Cell Biology. read more »